Specifically, the course objectives are threefold: to develop stronger leadership competencies, which are demonstrated through action; to ensure a shared leadership understanding throughout Bruker BioSpin; and to provide a shared leadership culture.

The Bruker BioSpin Group designs, manufactures, and distributes instruments based on magnetic resonance technology, including our world-class nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) spectrometers.

Bruker's differentiated high-value life science research and diagnostics solutions enable scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.

Bruker BioSpin | 32,238 followers on LinkedIn. High-Performance Magnetic Resonance (NMR, EPR) & Preclinical Imaging (MRI, NMI, mCT, MPI) Scientific Instruments.

It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments (Bruker AXS, Bruker BioSpin, Bruker Daltonics and Bruker Optics) and Bruker Energy & Supercon Technologies (BEST) divisions.

Bruker offers the world`s most comprehensive range of NMR and EPR spectroscopy and preclinical imaging research tools. The Bruker BioSpin Group of companies develop, manufacture and supply technol ...

Bruker BioSpin Group develops, manufactures, and markets instruments based on magnetic resonance technology, such as nuclear magnetic resonance (NMR), electron paramagnetic resonance (EPR)...

Discover essential consumables, cutting-edge accessories, and software for your Bruker BioSpin scientific instruments. Use the discount code SysDiscBioSpin@Store at checkout to get at least 10% off your next online order, valid for one use per customer.

Nov 14, 2024 · Bruker BioSpin Group, headquartered in Zurich, has acquired the electron paramagnetic resonance business of Bridge12, a Massachusetts-based company known for enabling cutting-edge research using EPR technology. The deal adds to Bruker’s suite of EPR spectroscopy offerings.

ZUERICH, Switzerland – October 7th, 2024: Bruker BioSpin Group today announced the acquisition of the Electron Paramagnetic Resonance (EPR) business of Bridge12, a Massachusetts-based company (www.bridge12.com).